搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Pichia pastoris Restriction of telomere capping protein 5 (RTC5), partial CSB-YP505270EVR
CSB-EP505270EVR
CSB-BP505270EVR
CSB-MP505270EVR
CSB-EP505270EVR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pichia pastoris Arginine biosynthesis bifunctional protein ArgJ, mitochondrial (PAS_chr3_0176), partial CSB-YP505271EVR
CSB-EP505271EVR
CSB-BP505271EVR
CSB-MP505271EVR
CSB-EP505271EVR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pichia pastoris Golgi to ER traffic protein 2 (GET2), partial CSB-YP505272EVR1
CSB-EP505272EVR1
CSB-BP505272EVR1
CSB-MP505272EVR1
CSB-EP505272EVR1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pichia pastoris Mitochondrial distribution and morphology protein 12 (MDM12) CSB-YP505273EVR
CSB-EP505273EVR
CSB-BP505273EVR
CSB-MP505273EVR
CSB-EP505273EVR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pichia pastoris Protein SEY1 (SEY1), partial CSB-YP505274EVR1
CSB-EP505274EVR1
CSB-BP505274EVR1
CSB-MP505274EVR1
CSB-EP505274EVR1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pichia pastoris Oxidant-induced cell-cycle arrest protein 5 (OCA5), partial CSB-YP505275EVR
CSB-EP505275EVR
CSB-BP505275EVR
CSB-MP505275EVR
CSB-EP505275EVR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pichia pastoris Pentafunctional AROM polypeptide (ARO1), partial CSB-YP505276EVR
CSB-EP505276EVR
CSB-BP505276EVR
CSB-MP505276EVR
CSB-EP505276EVR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pichia pastoris Tethering factor for nuclear proteasome STS1 (STS1) CSB-YP505277EVR
CSB-EP505277EVR
CSB-BP505277EVR
CSB-MP505277EVR
CSB-EP505277EVR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pichia pastoris Ubiquinone biosynthesis protein COQ4, mitochondrial (COQ4), partial CSB-YP505278EVR
CSB-EP505278EVR
CSB-BP505278EVR
CSB-MP505278EVR
CSB-EP505278EVR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pichia pastoris Mitochondrial group I intron splicing factor CCM1 (CCM1), partial CSB-YP505279EVR
CSB-EP505279EVR
CSB-BP505279EVR
CSB-MP505279EVR
CSB-EP505279EVR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pichia pastoris Probable zinc metalloprotease PAS_chr3_0953 (PAS_chr3_0953), partial CSB-YP505280EVR
CSB-EP505280EVR
CSB-BP505280EVR
CSB-MP505280EVR
CSB-EP505280EVR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pichia pastoris Nuclear distribution protein PAC1 (PAC1) CSB-YP505281EVR
CSB-EP505281EVR
CSB-BP505281EVR
CSB-MP505281EVR
CSB-EP505281EVR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pichia pastoris Regulator of rDNA transcription 14 (RRT14) CSB-YP505282EVR
CSB-EP505282EVR
CSB-BP505282EVR
CSB-MP505282EVR
CSB-EP505282EVR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pichia pastoris Methylthioribulose-1-phosphate dehydratase (MDE1) CSB-YP505283EVR
CSB-EP505283EVR
CSB-BP505283EVR
CSB-MP505283EVR
CSB-EP505283EVR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pichia pastoris Mitochondrial zinc maintenance protein 1, mitochondrial (MZM1) CSB-YP505284EVR
CSB-EP505284EVR
CSB-BP505284EVR
CSB-MP505284EVR
CSB-EP505284EVR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pichia pastoris Altered inheritance of mitochondria protein 11 (AIM11), partial CSB-YP505285EVR1
CSB-EP505285EVR1
CSB-BP505285EVR1
CSB-MP505285EVR1
CSB-EP505285EVR1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pichia pastoris Exonuclease V, mitochondrial (EXO5), partial CSB-YP505286EVR
CSB-EP505286EVR
CSB-BP505286EVR
CSB-MP505286EVR
CSB-EP505286EVR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pichia pastoris Golgi to ER traffic protein 1 (GET1), partial CSB-YP505287EVR1
CSB-EP505287EVR1
CSB-BP505287EVR1
CSB-MP505287EVR1
CSB-EP505287EVR1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pichia pastoris ATPase GET3 (GET3) CSB-YP505288EVR
CSB-EP505288EVR
CSB-BP505288EVR
CSB-MP505288EVR
CSB-EP505288EVR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pichia pastoris 40S ribosomal protein S1 (RPS1) CSB-YP505289EVR
CSB-EP505289EVR
CSB-BP505289EVR
CSB-MP505289EVR
CSB-EP505289EVR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>